New Leaf Venture Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-219,251
| Closed | -$12.1M | – | 21 |
|
|
2022
Q2 | $12.1M | Buy |
219,251
+93,740
| +75% | +$4.92M | 7.81% | 5 |
|
|
2022
Q1 | $4.02M | Sell |
125,511
-284,100
| -69% | -$8.15M | 1.98% | 11 |
|
|
2021
Q4 | $8.9M | Hold |
409,611
| – | – | 3.23% | 8 |
|
|
2021
Q3 | $8.98M | Hold |
409,611
| – | – | 2.59% | 8 |
|
|
2021
Q2 | $4.07M | Hold |
409,611
| – | – | 1.04% | 12 |
|
|
2021
Q1 | $7.06M | Hold |
409,611
| – | – | 1.64% | 8 |
|
|
2020
Q4 | $6.57M | Hold |
409,611
| – | – | 1.52% | 6 |
|
|
2020
Q3 | $4.37M | Hold |
409,611
| – | – | 1.76% | 8 |
|
|
2020
Q2 | $4.96M | Hold |
409,611
| – | – | 1.42% | 11 |
|
|
2020
Q1 | $4.02M | Buy |
409,611
+284,100
| +226% | +$3.72M | 1.2% | 10 |
|
|
2019
Q4 | $68.8M | Hold |
125,511
| – | – | 14.94% | 3 |
|
|
2019
Q3 | $1.96M | Hold |
125,511
| – | – | 0.59% | 18 |
|
|
2019
Q2 | $2.81M | Hold |
125,511
| – | – | 0.75% | 17 |
|
|
2019
Q1 | $8.59M | Hold |
125,511
| – | – | 2.35% | 10 |
|
|
2018
Q4 | $6.63M | Hold |
125,511
| – | – | 1.82% | 11 |
|
|
2018
Q3 | $8.54M | Hold |
125,511
| – | – | 1.55% | 12 |
|
|
2018
Q2 | $14.9M | Hold |
125,511
| – | – | 3.59% | 8 |
|
|
2018
Q1 | $10.4M | Buy |
125,511
+55,555
| +79% | +$6.3M | 5.61% | 6 |
|
|
2017
Q4 | $10.4M | Hold |
69,956
| – | – | 4.88% | 7 |
|
|
2017
Q3 | $4.34M | Buy |
69,956
+1,354
| +2% | +$79.4K | 2.01% | 9 |
|
|
2017
Q2 | $3.21M | Buy |
68,602
+3,787
| +6% | +$193K | 2.26% | 9 |
|
|
2017
Q1 | $3.97M | Buy |
+64,815
| New | +$3.77M | 2.03% | 9 |
|
Other funds holding SRRA
New Leaf Venture Partners's SRRA Position: Q3 2022 in Review
New Leaf Venture Partners sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 219,251 shares — an estimated $12.1M sold.
New Leaf Venture Partners first reported a position in SRRA in Q1 2017 and held it in 22 quarters. The position peaked at $68.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- New Leaf Venture Partners reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- New Leaf Venture Partners sold 219,251 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $12.1M.
- New Leaf Venture Partners first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2017 and held it in 22 quarters.
- New Leaf Venture Partners's Sierra Oncology, Inc. Common Stock position peaked at $68.8M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on New Leaf Venture Partners's 13F filing for Q3 2022, filed 10 Nov 2022.